In the last trading session, 1.2 million Olema Pharmaceuticals Inc (NASDAQ:OLMA) shares changed hands as the company’s beta touched 2.00. With the company’s per share price at $4.21 changed hands at -$0.17 or -3.88% during last session, the market valuation stood at $288.06M. OLMA’s last price was a discount, traded about -294.77% off its 52-week high of $16.62. The share price had its 52-week low at $2.86, which suggests the last value was 32.07% up since then.
Analysts gave the Olema Pharmaceuticals Inc (OLMA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended OLMA as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Olema Pharmaceuticals Inc’s EPS for the current quarter is expected to be -0.45.
Olema Pharmaceuticals Inc (NASDAQ:OLMA) trade information
Instantly OLMA was in red as seen at the end of in last trading. With action 3.95%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -27.79%, with the 5-day performance at 3.95% in the green. However, in the 30-day time frame, Olema Pharmaceuticals Inc (NASDAQ:OLMA) is -8.48% down.
The consensus price target for the stock as assigned by Wall Street analysts is 28.5, meaning bulls need an upside of 85.23% from its current market value. According to analyst projections, OLMA’s forecast low is 27 with 30 as the target high. To hit the forecast high, the stock’s price needs a -612.59% plunge from its current level, while the stock would need to soar -541.33% for it to hit the projected low.
Olema Pharmaceuticals Inc (OLMA) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -83.00%. The 2025 estimates are for Olema Pharmaceuticals Inc earnings to increase by 12.18%, but the outlook for the next 5-year period is at 6.25% per year.
Olema Pharmaceuticals Inc (NASDAQ:OLMA)’s Major holders
PARADIGM BIOCAPITAL ADVISORS LP holds the second largest percentage of outstanding shares, with 14.0428% or 7.9 million shares worth $85.52 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 1.63 shares estimated at $6.87 million under it, the former controlled 2.38% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.47% of the shares, roughly 1.01 shares worth around $4.24 million.
